Vault-13

Decheng Capital LLC

MENLO PARK, CA · CIK 2010850 · 13F filing filed 2025-08-13

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$396.0m reported value +11.1% vs Q1 2025
25positions
92.4%in top 10
1 new 3 added 8 reduced 3 sold out vs Q1 2025

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CG ONCOLOGY INC COM CGON CGON 6,371,669 $165.7m41.84% 41.84% UnchangedShares held: Q3 2024 5.5m, Q4 2024 6.4m, Q1 2025 6.4m, Q2 2025 6.4m
2 AARDVARK THERAPEUTICS INC COM AARD AARD 3,917,299 $53.0m13.38% 13.38% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 3.9m, Q2 2025 3.9m
3 NUVATION BIO INC COM CL A NUVB NUVB 25,954,439 $50.6m12.78% 12.78% UnchangedShares held: Q3 2024 26.0m, Q4 2024 26.0m, Q1 2025 26.0m, Q2 2025 26.0m
4 UPSTREAM BIO INC COM UPB UPB 3,285,293 $36.1m9.11% 9.11% UnchangedShares held: Q3 2024 0, Q4 2024 3.3m, Q1 2025 3.3m, Q2 2025 3.3m
5 NEWAMSTERDAM PHARMA COMPANY ORDINARY SHARES NAMS NAMS 770,000 $13.9m3.52% 3.52% UnchangedShares held: Q3 2024 590.0k, Q4 2024 770.0k, Q1 2025 770.0k, Q2 2025 770.0k
6 BEYONDSPRING INC SHS BYSI BYSI 4,531,481 $10.6m2.69% 2.69% ReducedShares held: Q3 2024 5.0m, Q4 2024 4.9m, Q1 2025 4.9m, Q2 2025 4.5m -351.2k -351,170 -7.2%
7 MERUS N V COM MRUS MRUS 189,098 $9.9m2.51% 2.51% UnchangedShares held: Q3 2024 189.1k, Q4 2024 189.1k, Q1 2025 189.1k, Q2 2025 189.1k
8 KRYSTAL BIOTECH INC COM KRYS KRYS 66,000 $9.1m2.29% 2.29% AddedShares held: Q3 2024 71.8k, Q4 2024 76.8k, Q1 2025 65.0k, Q2 2025 66.0k +1.0k +1,000 1.5%
9 MOONLAKE IMMUNOTHERAPEUTICS COM MLTX MLTX 181,600 $8.6m2.16% 2.16% AddedShares held: Q3 2024 166.6k, Q4 2024 171.6k, Q1 2025 171.6k, Q2 2025 181.6k +10.0k +10,000 5.8%
10 REVOLUTION MEDICINES INC COM RVMD RVMD 226,000 $8.3m2.10% 2.10% UnchangedShares held: Q3 2024 2.0k, Q4 2024 226.0k, Q1 2025 226.0k, Q2 2025 226.0k
11 ACLARIS THERAPEUTICS INC COM ACRS ACRS 4,041,736 $5.7m1.45% 1.45% UnchangedShares held: Q3 2024 0, Q4 2024 2.3m, Q1 2025 4.0m, Q2 2025 4.0m
12 LYELL IMMUNOPHARMA INC COM COM 595,466 $5.3m1.33% 1.33% ReducedShares held: Q3 2024 0, Q4 2024 595.5k, Q1 2025 595.5k, Q2 2025 595.5k -1 -1 0.0%
13 ARCELLX INC COMMON STOCK ACLX ACLX 547,609 $4.5m1.13% 1.13% AddedShares held: Q3 2024 21.2k, Q4 2024 84.4k, Q1 2025 50.0k, Q2 2025 547.6k +497.6k +497,609 995.2%
14 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 143,000 $4.1m1.04% 1.04% ReducedShares held: Q3 2024 158.0k, Q4 2024 168.0k, Q1 2025 178.0k, Q2 2025 143.0k -35.0k -34,958 -19.6%
15 AURA BIOSCIENCES INC COM AURA AURA 515,555 $3.2m0.82% 0.82% UnchangedShares held: Q3 2024 515.6k, Q4 2024 515.6k, Q1 2025 515.6k, Q2 2025 515.6k
16 ZENTALIS PHARMACEUTICALS INC COM ZNTL ZNTL 1,323,327 $1.5m0.39% 0.39% ReducedShares held: Q3 2024 3.1m, Q4 2024 2.3m, Q1 2025 2.0m, Q2 2025 1.3m -696.4k -696,435 -34.5%
17 EQUILLIUM INC COM EQ EQ 4,447,308 $1.4m0.35% 0.35% UnchangedShares held: Q3 2024 4.4m, Q4 2024 4.4m, Q1 2025 4.4m, Q2 2025 4.4m
18 4D MOLECULAR THERAPEUTICS IN COM FDMT FDMT 239,510 $888.6k0.22% 0.22% ReducedShares held: Q3 2024 397.8k, Q4 2024 400.0k, Q1 2025 335.5k, Q2 2025 239.5k -96.0k -96,005 -28.6%
19 ARCUS BIOSCIENCES INC COM RCUS RCUS 160,000 $811.2k0.20% 0.20% ReducedShares held: Q3 2024 869.8k, Q4 2024 808.8k, Q1 2025 808.8k, Q2 2025 160.0k -648.8k -648,789 -80.2%
20 ILLUMINA INC COM ILMN ILMN 7,979 $761.3k0.19% 0.19% ReducedShares held: Q3 2024 94.8k, Q4 2024 94.8k, Q1 2025 11.7k, Q2 2025 8.0k -3.8k -3,770 -32.1%
21 LEGEND BIOTECH CORP SPONSORED ADS LEGN LEGN 20,000 $709.8k0.18% 0.18% ReducedShares held: Q3 2024 108.6k, Q4 2024 153.6k, Q1 2025 100.0k, Q2 2025 20.0k -80.0k -80,000 -80.0%
22 GRAIL INC COM GRAL GRAL 9,684 $498.0k0.13% 0.13% UnchangedShares held: Q3 2024 9.7k, Q4 2024 9.7k, Q1 2025 9.7k, Q2 2025 9.7k
23 PYXIS ONCOLOGY INC COMMON STOCK PYXS PYXS 326,810 $359.5k0.09% 0.09% UnchangedShares held: Q3 2024 326.8k, Q4 2024 326.8k, Q1 2025 326.8k, Q2 2025 326.8k
24 REZOLUTE INC COM NEW RZLT RZLT 59,900 $267.2k0.07% 0.07% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 59.9k
25 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 646,057 $127.3k0.03% 0.03% UnchangedShares held: Q3 2024 646.1k, Q4 2024 646.1k, Q1 2025 646.1k, Q2 2025 646.1k

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
CYTOKINETICS INC CYTK CYTK 100,000 $4.0m100.0k shares
BIONTECH SE BNTX BNTX 20,000 $1.8m20.0k shares
VERA THERAPEUTICS INC VERA VERA 4,495 $108.0k4.5k shares